Document Detail


B cell acute lymphocytic leukemia in pregnancy.
MedLine Citation:
PMID:  20717686     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute lymphocytic leukemia (ALL) is a rare occurrence in pregnancy and can be rapidly fatal if left untreated. The need for immediate treatment of ALL, coupled with the maternal-fetal risks from the chemotherapy regimen render a therapeutic dilemma in pregnant women with ALL. We report a case of ALL diagnosed in the 24th week of pregnancy to outline our management strategy, to demonstrate the feasibility of treatment with multi-agent chemotherapy, and to provide a review of the literature.
Authors:
Justin Bottsford-Miller; Sina Haeri; Arthur M Baker; Jeremiah Boles; Mark Brown
Related Documents :
7156326 - Idiopathic acute fatty liver of pregnancy in 12 patients.
23990966 - Reduction of maternal mortality with highly active antiretroviral therapy in a large co...
21764886 - Maternal-fetal epigenetic interactions in the beginning of cardiovascular damage.
24679596 - Fetal blood grouping using cell free dna - an improved service for rhd negative pregnan...
20541736 - Impact of antenatal selective serotonin reuptake inhibitor exposure on pregnancy outcom...
10946386 - "a tempest in a cocktail glass": mothers, alcohol, and television, 1977-1996.
Publication Detail:
Type:  Case Reports; Journal Article; Review     Date:  2010-08-18
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  284     ISSN:  1432-0711     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-12     Completed Date:  2011-12-21     Revised Date:  2014-11-14    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  303-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Gestational Age
Humans
Leukemia, B-Cell / complications,  drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications,  drug therapy*
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*
Pregnancy Outcome
Grant Support
ID/Acronym/Agency:
T32 CA101642/CA/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma.
Next Document:  HIV testing in pregnancy: are we testing enough?